LIXT Stock: Lixte Biotechnology Holdings, Inc. Stock Price, Analysis & Insights
Get live LIXT stock price $6.85, comprehensive Lixte Biotechnology Holdings, Inc. stock analysis, charts, news, and expert forecast. Real-time LIXT stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Lixte Biotechnology Holdings, Inc. is a drug discovery company focused on developing new treatments. It employs biomarker technology to identify crucial enzyme targets associated with serious, widespread diseases, then designs innovative compounds to...
Company Information
- CEO
- Geordan G. Pursglove
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 2
Contact Information
- Website
- https://lixte.com
- Address
- 680 East Colorado Boulevard
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Lixte Biotechnology Holdings, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Lixte Biotechnology Holdings, Inc.
- ⚠Investors should consider how Lixte Biotechnology Holdings, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
84.82M
P/E Ratio (TTM)
-5.66
Beta
1.05
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare LIXT with peer companies:
- Price
- $1.58
- Market cap
- 25.14M
- Price
- $3.03
- Market cap
- 5.70M
- Price
- $0.15
- Market cap
- 2.33M
- Price
- $4.70
- Market cap
- 26.35M
- Price
- $0.41
- Market cap
- 2.15M
- Price
- $2.85
- Market cap
- 13.58M
- Price
- $1.21
- Market cap
- 16.04M
- Price
- $0.44
- Market cap
- 9.42M
- Price
- $0.69
- Market cap
- 14.00M
- Price
- $1.34
- Market cap
- 4.89M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.